Drug Profile
Research programme: USP15 protein inhibitors - Corbin Therapeutics/University of Dundee
Latest Information Update: 28 Jun 2021
Price :
$50
*
At a glance
- Originator Corbin Therapeutics; University of Dundee
- Class Anti-inflammatories; Small molecules
- Mechanism of Action USP15 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 28 Jun 2021 No recent reports of development identified for research development in Inflammation in Canada
- 28 Jun 2021 No recent reports of development identified for research development in Inflammation in Scotland
- 22 May 2017 University of Dundee and Corbin Therapeutics agree to co-develop USP15 protein inhibitors for Inflammation